| 000 | 01269 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515131406.0 | ||
| 264 | 0 | _c20081118 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0b013e31817ffe5a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReasner, Charles A | |
| 245 | 0 | 0 |
_aReducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cAug 2008 |
||
| 300 |
_a136-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xdrug therapy |
| 650 | 0 | 4 |
_aHypertriglyceridemia _xdrug therapy |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 52 _gno. 2 _gp. 136-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0b013e31817ffe5a _zAvailable from publisher's website |
| 999 |
_c18146741 _d18146741 |
||